Up-regulation of Nek1 in glioma tissue correlated with the clinical grade and Karnofsky performance scale, and was significantly associated with a poor OS, while an siRNA-mediated KD of Nek1 sensitized glioblastoma cells to the drug temozolomide [23]. The gene discussed is NEK1; the disease is central nervous system cancer.